Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Neurotoxicity Research
|
September 27, 2006
The neurotoxin, MPP+, induces hyperphosphorylation of Tau, in the presence of alpha-Synuclein, in SH-SY5Y neuroblastoma cells
Tetyana Duka, Anita Sidhu
Brain, Behavior and Evolution
|
October 26, 2012
Now that we've got the map, where are we going? Moving from gene candidate lists to function in studies of brain evolution
Chet C Sherwood, Tetyana Duka
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 17, 2009
Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models
Tetyana Duka, Valeriy Duka, Jeffrey N Joyce, et al.
Cancers
|
June 22, 2023
Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic
Gurbani Jolly, Tetyana Duka, Narayan Shivapurkar, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 2, 2006
Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of parkinsonism
Tetyana Duka, Milan Rusnak, Robert E Drolet, et al.
Brain Structure & Function
|
November 5, 2013
Aerobic glycolysis in the primate brain: reconsidering the implications for growth and maintenance
Amy L Bauernfeind, Sarah K Barks, Tetyana Duka, et al.
Journal of Neurochemistry
|
August 18, 2004
Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells
Hong Liao, Tetyana Duka, Felicia Y H Teng, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
January 22, 2024
Implicating the cholecystokinin B receptor in liver stem cell oncogenesis
Martha D Gay, Jack C Drda, Wenqiang Chen, et al.
International Journal of Molecular Sciences
|
February 25, 2023
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma
Narayan Shivapurkar, Martha D Gay, Aiwu Ruth He, et al.
Chemmedchem
|
August 8, 2006
Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson's disease
Alan P Kozikowski, Irina N Gaisina, Pavel A Petukhov, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Neurotoxicity Research
|
September 27, 2006
The neurotoxin, MPP+, induces hyperphosphorylation of Tau, in the presence of alpha-Synuclein, in SH-SY5Y neuroblastoma cells
Tetyana Duka, Anita Sidhu
Brain, Behavior and Evolution
|
October 26, 2012
Now that we've got the map, where are we going? Moving from gene candidate lists to function in studies of brain evolution
Chet C Sherwood, Tetyana Duka
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 17, 2009
Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models
Tetyana Duka, Valeriy Duka, Jeffrey N Joyce, et al.
Cancers
|
June 22, 2023
Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic
Gurbani Jolly, Tetyana Duka, Narayan Shivapurkar, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 2, 2006
Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of parkinsonism
Tetyana Duka, Milan Rusnak, Robert E Drolet, et al.
Brain Structure & Function
|
November 5, 2013
Aerobic glycolysis in the primate brain: reconsidering the implications for growth and maintenance
Amy L Bauernfeind, Sarah K Barks, Tetyana Duka, et al.
Journal of Neurochemistry
|
August 18, 2004
Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells
Hong Liao, Tetyana Duka, Felicia Y H Teng, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
January 22, 2024
Implicating the cholecystokinin B receptor in liver stem cell oncogenesis
Martha D Gay, Jack C Drda, Wenqiang Chen, et al.
International Journal of Molecular Sciences
|
February 25, 2023
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma
Narayan Shivapurkar, Martha D Gay, Aiwu Ruth He, et al.
Chemmedchem
|
August 8, 2006
Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson's disease
Alan P Kozikowski, Irina N Gaisina, Pavel A Petukhov, et al.
Page
of 2